{
    "clinical_study": {
        "@rank": "41780", 
        "arm_group": [
            {
                "arm_group_label": "Active", 
                "arm_group_type": "Experimental", 
                "description": "ANT-1403"
            }, 
            {
                "arm_group_label": "Vehicle", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Vehicle"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to confirm the effect of ANT-1403 in the treatment of primary\n      axillary hyperhidrosis."
        }, 
        "brief_title": "Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Primary Axillary Hyperhidrosis", 
        "condition_browse": {
            "mesh_term": "Hyperhidrosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ages 18 - 70 years of age\n\n          -  diagnosis of moderate to severe primary axillary hyperhidrosis\n\n          -  \u226550 mg of sweat production/axilla in 5 minutes as measured gravimetrically\n\n          -  HDSS score of \u22653\n\n        Exclusion Criteria:\n\n          -  diagnosis of secondary hyperhidrosis\n\n          -  skin affliction in the axilla requiring medical treatment\n\n          -  20% aluminum hydrochloride, e.g. Drysol\u00ae, in 2 weeks prior of Baseline\n\n          -  oral anticholinergic treatment\n\n          -  botulinum toxin treatment in the prior 9 months\n\n          -  history of surgery for axillary hyperhidrosis\n\n          -  present or history of neuromuscular disease\n\n          -  female subjects who are pregnant or are nursing a child"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "52", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01799824", 
            "org_study_id": "ANT-1403-HHID-202"
        }, 
        "intervention": [
            {
                "arm_group_label": "Active", 
                "intervention_name": "ANT-1403", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "Vehicle", 
                "intervention_name": "placebo", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 15, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33137"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pinellas Park", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33781"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "West Palm Beach", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33401"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40202"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "East Windsor", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08520"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14623"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Raleigh", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27612"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yardley", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19067"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norfolk", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23507"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis in Adults", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "HDSS", 
            "safety_issue": "No", 
            "time_frame": "Week 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01799824"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "GSP", 
            "safety_issue": "No", 
            "time_frame": "Week 8"
        }, 
        "source": "Anterios Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Anterios Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}